RIGVIR is a virus therapy that has been promoted to treat melanoma.
The drug consists of live viruses that cannot cause disease. According to the manufacturer, the viruses specifically infect tumor cells and lead to their death.
RIGVIR was approved in Latvia for the treatment of melanoma. The approval has been withdrawn recently.
I do not recommend RIGVIR because there has been controversy about the quality of the product in the past.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.